CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Paid-in Capital	Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Treasury Stock	Nonredeemable Noncontrolling Interests
Beginning balance (in shares) at Jan. 29, 2022			62,697,032
Beginning balance at Jan. 29, 2022	$ 653,643	$ (21,723)	$ 627	$ 565,024	$ (43,078)	$ 1,158,664	$ 21,355	$ (135,549)	$ (966,108)	$ 30,985
Beginning balance (in shares) at Jan. 29, 2022									80,074,914
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)	10,454					7,970				2,484
Other comprehensive income (loss), net of income tax	(11,640)							(11,164)		(476)
Issuance of common stock under stock compensation plans (in shares)			411,785						411,785
Issuance of common stock under stock compensation plans	1,470		$ 4	(3,608)					$ 5,074
Issuance of stock under Employee Stock Purchase Plan (in shares)			10,976						10,976
Issuance of stock under Employee Stock Purchase Plan	206			69					$ 137
Share-based compensation	4,052			4,003		49
Dividends, net of forfeitures on non-participating securities	(13,659)					(13,659)
Share repurchases (in shares)			(3,789,576)						(3,789,576)
Share repurchases	(81,747)		$ (38)	38					$ (81,747)
Noncontrolling interest capital distribution	(4,817)									(4,817)
Equity forward contract issuance	(105,000)			(105,000)
Ending balance (in shares) at Apr. 30, 2022			59,330,217
Ending balance at Apr. 30, 2022	$ 431,239		$ 593	417,448		1,174,379		(146,713)	$ (1,042,644)	28,176
Ending balance (in shares) at Apr. 30, 2022									83,441,729
Beginning balance (in shares) at Jan. 28, 2023	54,609,786		54,609,786
Beginning balance at Jan. 28, 2023	$ 572,751		$ 546	532,398		1,276,857		(134,073)	$ (1,141,615)	38,638
Beginning balance (in shares) at Jan. 28, 2023	88,161,467								88,161,467
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)	$ (10,694)					(11,805)				1,111
Other comprehensive income (loss), net of income tax	(4,095)							(5,404)		1,309
Issuance of common stock under stock compensation plans (in shares)			1,085,319						1,085,319
Issuance of common stock under stock compensation plans	(450)		$ 11	(14,519)					$ 14,058
Issuance of stock under Employee Stock Purchase Plan (in shares)			11,848						11,848
Issuance of stock under Employee Stock Purchase Plan	181			28					$ 153
Share-based compensation	4,620			4,617		3
Dividends, net of forfeitures on non-participating securities	(12,662)					(12,662)
Share repurchases (in shares)			(2,237,872)						(2,237,872)
Share repurchases	(42,821)		$ (22)	22					$ (42,821)
Equity component value of convertible notes transactions, net	(744)			(744)
Sale of common stock warrant	20,158			20,158
Purchase of convertible note hedge	(39,397)			(39,397)
Termination of common stock warrant	(1,024)			(1,024)
Termination of convertible note hedge	$ 7,235			7,235
Ending balance (in shares) at Apr. 29, 2023	53,469,081		53,469,081
Ending balance at Apr. 29, 2023	$ 493,058		$ 535	$ 508,774		$ 1,252,393		$ (139,477)	$ (1,170,225)	$ 41,058
Ending balance (in shares) at Apr. 29, 2023	89,302,172								89,302,172